ClinicalTrials.Veeva

Menu

Remote Ischemic Preconditioning in ACS Patients

Henry Ford Health logo

Henry Ford Health

Status

Withdrawn

Conditions

Acute Coronary Syndrome
Ischemia, Myocardial
Renal Insufficiency

Treatments

Procedure: Remote Ischemic Preconditioning

Study type

Interventional

Funder types

Other

Identifiers

NCT03329612
RIPC in ACS

Details and patient eligibility

About

Remote ischemic preconditioning is a process of serial blood pressure cuff inflations and deflations that are performed prior to a procedure and have been shown in various other areas (coronary bypass surgery, vascular surgery, ST elevation myocardial infarctions) to decrease the rates of adverse events related to ischemic burden and renal injury. This procedure has not yet been studied in the population presenting with an acute coronary syndrome (ACS), even though ACS patients represent the majority of patients seen in the catheterization lab. The purpose of this study is to evaluate the efficacy of this simple and safe procedure in this particular population.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presenting with an acute coronary syndrome including non-ST elevation myocardial infarction or unstable angina on optimal medical therapy with aspirin, P2Y12 inhibitors, unfractionated heparin, statin, +/- beta blocker, +/- ace inhibitor

Exclusion criteria

  • Presenting with ST elevation myocardial infarction
  • Patients requiring circulatory support
  • Need for emergent percutaneous coronary intervention
  • Systemic hypotension (systolic blood pressure <90 mmHg)
  • Patients in cardiogenic shock defined by requiring inotropes or vasopressors
  • Patients currently on hemodialysis
  • Presence of an arteriovenous dialysis fistula or graft or lymphedema in either arm
  • Patients enrolled in other active cardiovascular investigational studies
  • Severe comorbidities with a life expectancy of less than 6 months
  • Pregnant or lactating women
  • Patients unable to provide consent
  • Patient taking the medication glibenclamide for treatment of diabetes

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

Intervention
Experimental group
Description:
This group will undergo remote ischemic preconditioning with serial inflations of the blood pressure cuff to 200 mmHg followed by deflation for reperfusion for a period of 5 minutes each for a total of 4 cycles.
Treatment:
Procedure: Remote Ischemic Preconditioning
Control
Sham Comparator group
Description:
This group will undergo serial inflations of the blood pressure cuff to 40 mmHg followed by deflation for a period of 5 minutes each for a total of 4 cycles.
Treatment:
Procedure: Remote Ischemic Preconditioning

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems